Evercore ISI raised the firm’s price target on Procter & Gamble to $183 from $180 and keeps an Outperform rating on the shares. Procter is “comping remarkably well” in the U.S., Europe and “enterprise” markets mainly in Latin America, which represent in aggregate 85% of sales and likely of profits, but the firm has adjusted its Q2 estimates to account for another round of China risk, the analyst tells investors in a post-earnings note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on PG:

• Netflix reports Q3 beat, CVS CEO Lynch steps down: Morning Buzz

• Procter & Gamble Highlights Market Trends and Regulations

• PG Earnings: Procter & Gamble Beats Earnings but Misses Sales Estimates in Q1

• Unusually active option classes on open October 18th

• Procter & Gamble says promotional market stable, slightly below pre-Covid levels